Sera Prognostics, Inc.
PreTRM® test volume increases 54% sequentially and approximately five-fold from 1Q26
Ordering healthcare providers increase 34% sequentially and approximately three-fold from 1Q26
Company newsroom
Sera Prognostics, Inc.
NASDAQ:SERA
1 releases